JP2006511471A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006511471A5 JP2006511471A5 JP2004536624A JP2004536624A JP2006511471A5 JP 2006511471 A5 JP2006511471 A5 JP 2006511471A5 JP 2004536624 A JP2004536624 A JP 2004536624A JP 2004536624 A JP2004536624 A JP 2004536624A JP 2006511471 A5 JP2006511471 A5 JP 2006511471A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- antibody
- mesangial
- nephritis
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41113702P | 2002-09-16 | 2002-09-16 | |
| PCT/US2003/029414 WO2004024098A2 (en) | 2002-09-16 | 2003-09-16 | Method for the treatment of nephritis using anti-pdgf-dd antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006511471A JP2006511471A (ja) | 2006-04-06 |
| JP2006511471A5 true JP2006511471A5 (cg-RX-API-DMAC7.html) | 2006-11-02 |
Family
ID=31994243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004536624A Pending JP2006511471A (ja) | 2002-09-16 | 2003-09-16 | 抗ｐｄｇｆ−ｄｄ抗体を用いた腎炎の処置方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040141969A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1549343A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2006511471A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2003272547A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2499207A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2004024098A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7658924B2 (en) | 2001-10-11 | 2010-02-09 | Amgen Inc. | Angiopoietin-2 specific binding agents |
| EP1539235A2 (en) * | 2002-07-01 | 2005-06-15 | Human Genome Sciences, Inc. | Antibodies that specifically bind to reg iv |
| PE20071101A1 (es) * | 2005-08-31 | 2007-12-21 | Amgen Inc | Polipeptidos y anticuerpos |
| WO2007059234A1 (en) * | 2005-11-10 | 2007-05-24 | Curagen Corporation | Method for the treatment of pdgf-d related diseases using anit-pdgf-dd antibodies |
| WO2007146160A2 (en) * | 2006-06-07 | 2007-12-21 | Curagen Corporation | Methods for the treatment of renal disease using anti-pdgf-dd antibodies |
| MX340916B (es) | 2008-01-18 | 2016-07-29 | President And Fellows Of Harvard College * | Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales. |
| JO2913B1 (en) | 2008-02-20 | 2015-09-15 | امجين إنك, | Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses |
| CA2806296A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting kidney-associated diseases or conditions |
| AU2011280997A1 (en) | 2010-07-23 | 2013-02-28 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
| TW201209171A (en) | 2010-07-23 | 2012-03-01 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
| EP2596132A4 (en) | 2010-07-23 | 2013-12-18 | Harvard College | METHOD FOR DETECTING SIGNS FOR ILLNESS OR SUFFERING IN BODY FLUIDS |
| US20130203624A1 (en) | 2010-07-23 | 2013-08-08 | President And Fellows Of Harvard College | Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions |
| NZ771629A (en) | 2013-03-09 | 2022-12-23 | Harry Stylli | Methods of detecting cancer |
| WO2014164362A1 (en) | 2013-03-09 | 2014-10-09 | Harry Stylli | Methods of detecting prostate cancer |
| US10626464B2 (en) | 2014-09-11 | 2020-04-21 | Cell Mdx, Llc | Methods of detecting prostate cancer |
| TW201702272A (zh) | 2015-05-22 | 2017-01-16 | 美國紀念斯隆 凱特琳癌症中心 | Ｐｒａｍｅ肽專一性類ｔ細胞受體抗體 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5620687A (en) * | 1993-02-25 | 1997-04-15 | Zymogenetics, Inc. | Inhibition of intimal hyperplasia using antibodies to PDGF beta receptors |
| US5916771A (en) * | 1996-10-11 | 1999-06-29 | Abgenix, Inc. | Production of a multimeric protein by cell fusion method |
| ATE556090T1 (de) * | 1998-11-10 | 2012-05-15 | Ludwig Inst Cancer Res | Verkürzter, von blutplättchen abstammender wachstumsfaktor d, dafür kodierendes dns und deren verwendung |
| US6630142B2 (en) * | 1999-05-03 | 2003-10-07 | Zymogenetics, Inc. | Method of treating fibroproliferative disorders |
| US7135174B2 (en) * | 2002-01-07 | 2006-11-14 | Amgen Fremont, Inc. | Antibodies directed to PDGFD and uses thereof |
-
2003
- 2003-09-16 US US10/665,383 patent/US20040141969A1/en not_active Abandoned
- 2003-09-16 CA CA002499207A patent/CA2499207A1/en not_active Abandoned
- 2003-09-16 JP JP2004536624A patent/JP2006511471A/ja active Pending
- 2003-09-16 AU AU2003272547A patent/AU2003272547A1/en not_active Abandoned
- 2003-09-16 EP EP03754734A patent/EP1549343A4/en not_active Withdrawn
- 2003-09-16 WO PCT/US2003/029414 patent/WO2004024098A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006511471A5 (cg-RX-API-DMAC7.html) | ||
| Kim et al. | First-in-human phase I study of aprutumab ixadotin, a fibroblast growth factor receptor 2 antibody–drug conjugate (BAY 1187982) in patients with advanced cancer | |
| Bhatia | Inflammatory response on the pancreatic acinar cell injury | |
| Cobleigh et al. | A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer | |
| RU2446796C2 (ru) | Способ использования ингибиторов гистондеацетилазы и мониторинга биомаркеров в комбинированной терапии | |
| Lee et al. | The monocyte chemoattractant protein-1 (MCP-1)/CCR2 system is involved in peritoneal dialysis-related epithelial–mesenchymal transition of peritoneal mesothelial cells | |
| Fontenot et al. | A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth | |
| JP2009539841A5 (cg-RX-API-DMAC7.html) | ||
| Pereira et al. | A brain-sparing diphtheria toxin for chemical genetic ablation of peripheral cell lineages | |
| Rentsch et al. | Time dependent degeneration of the nigrostriatal tract in mice with 6-OHDA lesioned medial forebrain bundle and the effect of activin A on l-Dopa induced dyskinesia | |
| ES2968038T3 (es) | Agonista GLP-1R de acción prolongada como terapia de afecciones neurológicas y neurodegenerativas | |
| JP2013532126A5 (cg-RX-API-DMAC7.html) | ||
| US20160046560A1 (en) | Compounds useful for the treatment of metabolic disorders and synthesis of the same | |
| Casagrande et al. | TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy | |
| Huang et al. | Systems pharmacology approach uncovers Ligustilide attenuates experimental colitis in mice by inhibiting PPARγ-mediated inflammation pathways | |
| Wang et al. | Chemokine CCL2 promotes cardiac regeneration and repair in myocardial infarction mice via activation of the JNK/STAT3 axis | |
| Liu et al. | Subcutaneous oxyntomodulin analogue administration reduces body weight in lean and obese rodents | |
| CA2329757A1 (en) | Use of .alpha.1.beta.1 integrin receptor inhibitors and tgf-.beta.1 inhibitors in the treatment of kidney disease | |
| HK1251512A1 (zh) | 靶向蛋白造影剂、其制备方法及用途 | |
| Wen et al. | Collapsed reticular network and its possible mechanism during the initiation and/or progression of hepatic fibrosis | |
| Liang et al. | Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis | |
| Dmochowska et al. | 89Zr-pro-MMP-9 F (ab′) 2 detects colitis induced intestinal and kidney fibrosis | |
| Guo et al. | Inhibition of Rac family protein impairs colitis and colitis-associated cancer in mice | |
| CN107949372A (zh) | 烯醇酶1（Eno1）组合物及其用途 | |
| JP2009506043A5 (cg-RX-API-DMAC7.html) |